Chief Scientific Officer @ (March 2025 - October 2025)
Vice President, Head of R and D @ (June 2024 - March 2025)
Vice President, Head of Preclinical R and D @ (February 2023 - June 2024)
Senior Director, Head of Preclinical R and D @ (January 2022 - February 2023)
Director, Nonclinical and Translational Research @ (December 2020 - January 2022)
Associate Director, Non-Clinical and Translational Research @ (September 2020 - December 2020)
Associate Director, Non-Clinical Research @ (January 2019 - September 2020)
Principal Scientist, Pharmacology @ (January 2018 - December 2018)
Scientist, Pharmacology @ (March 2017 - December 2017)
Postdoctoral Fellow @ (September 2015 - March 2017)
Graduate Student @ (August 2011 - August 2015)
Becca Senter Education
Vanderbilt University School of Medicine
Doctor of Philosophy (Ph.D.) (Pharmacology)
2011-2015
St. Lawrence University
Bachelor of Science (B.S.) (Neuroscience)
2006-2010
Becca Senter Skills
Pharmacology
Electrophysiology
Drug Discovery
Neuroscience
Animal Models
Biochemistry
Molecular Biology
Immunohistochemistry
Western Blotting
Fluorescence Microscopy
Cell Biology
HPLC
Research
Confocal Microscopy
PCR
Cell Culture
Gene Therapy
Toxicology
Good Laboratory Practice (GLP)
Becca Senter Summary
Becca Senter, based in Boston, MA, US, is currently a Chief Scientific Officer at Vertero Therapeutics, Inc.. Becca Senter brings experience from previous roles at Vertero Therapeutics, Inc.. Becca Senter holds a 2011 - 2015 Doctor of Philosophy (Ph.D.) in Pharmacology @ Vanderbilt University School of Medicine. With a robust skill set that includes Pharmacology, Electrophysiology, Drug Discovery, Neuroscience, Animal Models and more. Becca Senter has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Becca Senter?
Find contact details for 700 million professionals.